The preparation, characterization and pre-clinical evaluation of an orally administered HIV-I vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles
- 30 September 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 36 (1-2), 75-84
- https://doi.org/10.1016/0168-3659(95)00052-a
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Biodegradable microparticles for oral immunizationVaccine, 1993
- Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticlesVaccine, 1993
- Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibodyNature, 1992
- Long-Term High-Titer Neutralizing Activity Induced by Octameric Synthetic HIV-1 AntigenScience, 1991
- Women, HIV, and mucosal immunityThe Lancet, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- Development and Testing of AIDS VaccinesScience, 1988
- Prolonged delivery of peptides by microcapsulesJournal of Controlled Release, 1987
- Tissue Response to Biodegradable Injectable MicrocapsulesJournal of Biomaterials Applications, 1987
- T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?The Journal of Experimental Medicine, 1986